28 February 2023

Don’t wait until it’s too late to consider drug-drug interactions: Enzyme inhibition and induction evaluation

19 January 2023

Quantitative bioanalysis: your project, our team of experts!

22 September 2022

Admescope increases capacity and capability in high-quality service production through new investments

11 May 2022

Remember to characterize the physicochemical parameters of your compounds early on

26 April 2022

Symeres acquires Organix Inc., adding lipids expertise and a strategic foothold in the US

25 January 2022

Is your drug development program lacking in vitro drug-drug interaction data?

7 December 2021

In vivo metabolite identification and safety evaluation of human metabolites

21 October 2021

New article on physiologically based pharmacokinetic modeling

1 September 2021

Admescope team welcomes a new CEO!

26 August 2021

Do you need support with your Biologics project?

10 June 2021

New Admescope e-book is out!

25 May 2021

Press Release: Symeres, a leading European CRO and CDMO, joins forces with Keensight Capital

6 May 2021

An upcoming webinar via Symeres – In vivo pharmacokinetic experiments in preclinical drug development

13 April 2021

Admescope continues to be highly rated by the customers!

25 March 2021

Don't neglect the metabolites!